These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37329677)

  • 21. Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study.
    Salem MG; El-Maaty DMA; El-Deen YIM; Elesawy BH; Askary AE; Saleh A; Saied EM; Behery ME
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Antiproliferative Activity of New Thiosemicarboxamide Derivatives.
    Wu J; Guo Y; Chen J; Hu S; Sun K; Hu H; Fang M; Xue Y
    Chem Biodivers; 2021 Dec; 18(12):e2100671. PubMed ID: 34738709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer in vitro and in vivo.
    Yu N; Li N; Wang K; Deng Q; Lei Z; Sun J; Chen L
    Eur J Med Chem; 2021 Nov; 224():113701. PubMed ID: 34315044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of β-carboline derivatives with nitrogen mustard moieties against breast cancer.
    Sun J; Wang J; Wang X; Hu X; Cao H; Bai J; Li D; Hua H
    Bioorg Med Chem; 2021 Sep; 45():116341. PubMed ID: 34365102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis,
    Thaslim Basha SK; Mahaboob Basha S; Subba Rao D; Rasheed S; Varalakshmi M; Raju CN
    J Recept Signal Transduct Res; 2023 Dec; 43(6):144-153. PubMed ID: 38225858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAF
    Ali EMH; Mersal KI; Ammar UM; Zaraei SO; Abdel-Maksoud MS; El-Gamal MI; Haque MM; Das T; Kim EE; Lee JS; Lee KH; Kim HK; Oh CH
    Eur J Pharm Sci; 2022 Apr; 171():106115. PubMed ID: 34995782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, cytotoxicity, apoptosis and molecular docking studies of novel phenylbutyrate derivatives as potential anticancer agents.
    Mostoufi A; Baghgoli R; Fereidoonnezhad M
    Comput Biol Chem; 2019 Jun; 80():128-137. PubMed ID: 30952039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
    Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
    Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
    Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors.
    Wang R; Yu S; Zhao X; Chen Y; Yang B; Wu T; Hao C; Zhao D; Cheng M
    Eur J Med Chem; 2020 Feb; 188():112024. PubMed ID: 31923858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents.
    Ye T; Han Y; Wang R; Yan P; Chen S; Hou Y; Zhao Y
    Bioorg Chem; 2020 Jun; 99():103796. PubMed ID: 32283346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Furo[2,3-b]quinoline Derivatives with Anti-Breast Cancer Property by Targeting Topoisomerase II.
    Wang Y; Li N; Jiang N; Chen L; Sun J
    Anticancer Agents Med Chem; 2021; 21(12):1482-1489. PubMed ID: 33155915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
    Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
    Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
    Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
    Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
    Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S
    Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel ester tethered dihydroartemisinin-3-(oxime/thiosemicarbazide)isatin hybrids as potential anti-breast cancer agents: Synthesis, in vitro cytotoxicity and structure-activity relationship.
    Liu S; Wang S; Xu D; Pan B; Chen L; Zhao S; Xu Z; Zhou W
    Drug Dev Res; 2023 Sep; 84(6):1175-1182. PubMed ID: 37165798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs.
    Gagic Z; Ivkovic B; Srdic-Rajic T; Vucicevic J; Nikolic K; Agbaba D
    Eur J Pharm Sci; 2016 Jun; 88():59-69. PubMed ID: 27063330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
    Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
    Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.